News Focus
News Focus
icon url

Work Harder

09/14/20 6:08 PM

#20205 RE: bow-tie #20204

So that everyone is on the same plane

Isn't that interesting, manufacturing about to change here :?

From SP1 so thanks to him for this. I'll add that Gsk is big on liposomes w/ Operation Warp Speed

https://translate.google.com/translate?hl=en&sl=de&u=https://www.diepresse.com/5861311/teil-des-covid-19-impfstoffes-konnte-aus-osterreich-kommen&prev=search&pto=aue

So I added these

In that, check this out

https://www.fitforhealth.eu/cms/docs/Success_stories/Polymun_success_story.pdf

https://www.polymun.com/about-us/

Aint that interesting

from the Polymun link

Polymun started the development of a biosimilar rhFSH (follicle stimulating hormone) in 2006. Together with our license partner Finox AG, the drug product with the name Bemfola® was clinically tested successfully. Finox AG obtained market approval from EMA in April 2014. Since then, several other countries such as Australia, New Zealand and Israel have granted market approval for Bemfola®. Polymun remains the exclusive manufacturer of rhFSH as drug substance.

https://finoxbiotech.com/

nada much there but

Richter announces the acquisition of Finox Holding for a consideration of CHF190 million
6/30/2016

https://www.richter.hu/en-US/investors/announcements/Pages/extraord160630.aspx

https://www.richter.hu/en-US/our-activity/Pages/Pharmaceutical-manufacturing.aspx

https://www.richter.hu/en-US/richter-group/Pages/default.aspx

She's going to turn folks, release the hounds
icon url

Work Harder

09/14/20 8:47 PM

#20207 RE: bow-tie #20204

M.Sc. In Engineering Mathematics from the Technical University of Budapest

MBA from INSEAD (2000)

Zoltan Czigler spent some of his time getting a lil education in Germany did he ?

Yeow Bro

It's all about Austria right now

Kinda like the rich robbing from the poor

LOL